文献速递细菌感染、耐药与抗菌药物病毒性肝炎

肝硬化患者抗生素暴露与多重耐药菌出现的关联:前瞻性队列研究

Antibiotic exposure and the emergence of multidrug resistant bacteria in patients with liver cirrhosis: A prospective cohort study.
PubMed 文献 · Clin Infect Dis · 2026-10-09

该前瞻性队列在德国法兰克福大学医院纳入256例晚期慢性肝病成人,量化抗生素累积暴露与多重耐药菌(MDRO)新发获得的关系。246例首次入院拭子无MDRO者中,MDRO获得与累积抗生素暴露显著相关(p<0.001),VRE 20%概率阈值对应任何抗生素累积9.6 DDD。随访中新发MDRO与180天死亡率独立相关(HR 2.15,95%CI 1.27-3.64;p=0.004)。

要点

  • 累积抗生素暴露与晚期肝硬化患者MDRO新发获得显著相关。
  • VRE 20%概率阈值对应任何抗生素累积9.6 DDD。
  • 随访中新发MDRO与180天死亡率升高独立相关。

核心结论

  • 晚期肝硬化患者MDRO出现与超过特定类别阈值的累积抗生素暴露相关,并带来超额死亡风险。

研究设计与样本

  • 前瞻性队列研究,在德国法兰克福大学医院连续纳入256例晚期慢性肝病成人(2020-2023年)。
  • 抗生素暴露用限定日剂量(DDD)和抗生素使用密度(AUD)量化,MDRO定植和感染通过系统微生物监测捕获。
  • 死亡时间分析采用竞争风险框架,肝移植为竞争事件。

主要发现

  • 246例首次入院拭子无MDRO的患者中,新发获得耐万古霉素肠球菌(VRE)或革兰阴性MDR与累积抗生素暴露强烈相关(p<0.001)。
  • VRE 20%概率阈值在累积任何抗生素9.6 DDD时达到,β-内酰胺/β-内酰胺酶抑制剂复方、碳青霉烯类和糖肽类的阈值显著更低。
  • 随访期间新发MDRO检测(而非基线时)与180天死亡率升高独立相关(HR 2.15,95%CI 1.27-3.64;p=0.004)。

关键数值与推荐

  • VRE 20%概率阈值:累积任何抗生素9.6 DDD。
  • β-内酰胺/β-内酰胺酶抑制剂复方、碳青霉烯类和糖肽类的阈值显著低于任何抗生素的9.6 DDD。

临床怎么用

  • 在晚期肝硬化患者中可将累积抗生素负荷视为可干预的危险因素,支持采用暴露感知的抗菌药物管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infections caused by multidrug-resistant organisms (MDROs) are a growing concern in patients with advanced chronic liver disease and acute-on-chronic liver failure, worsening clinical outcomes. Although prior antibiotic exposure is associated with resistance, prospectively defined, clinically actionable exposure thresholds in this population are lacking. We aimed to quantify cumulative-exposure thresholds for de novo MDRO acquisition and assess the prognostic impact of MDRO emergence on survival. METHODS: We prospectively enrolled 256 consecutive adults with advanced chronic liver disease at the University Hospital Frankfurt (2020-2023). Antibiotic exposure was quantified using defined daily doses (DDD) and antibiotic use density (AUD); MDRO colonisation and infection were captured by systematic microbiological surveillance. Time-to-death was analysed in a competing-risk framework with liver transplantation as competing event. RESULTS: Among 246 patients without MDRO at the first admission swab, de novo acquisition of vancomycin-resistant enterococci (VRE) or Gram-negative MDR was strongly associated with cumulative antibiotic exposure (p<0.001). The 20% probability threshold for VRE was reached at 9.6 cumulative DDDs of any antibiotic, with substantially lower thresholds for β-lactam/β-lactamase inhibitor combinations, carbapenems, and glycopeptides. De novo MDRO detection during follow-up, but not at baseline, was independently associated with increased 180-day mortality (HR 2.15, 95% CI 1.27-3.64; p=0.004). CONCLUSIONS: In advanced cirrhosis, MDRO emergence is associated with cumulative antibiotic exposure beyond distinct, class-specific thresholds and carries excess mortality. These prospective findings identify cumulative antibiotic burden as a modifiable risk factor and support an exposure-aware approach to antimicrobial stewardship in this population.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Heilani MW, Wiedemann T, Best C, et al. Antibiotic exposure and the emergence of multidrug resistant bacteria in patients with liver cirrhosis: A prospective cohort study. Clin Infect Dis. 2026. PMID: 42852800. doi:10.1093/cid/ciag610

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。